Investor Relations

Company Overview

Quanta, Inc. ("Quanta") is a cutting-edge technology platform whose patented, proprietary technology harnesses advances in quantum biology to increase the potency of active ingredients. Currently, Quanta supports product formulations in pain management, anti-inflammation, skincare, anti-aging, nutritional supplements, and plant-based consumables. Ultimately, Quanta's mission is to deliver better, more effective ingredients to elevate product efficacy, reduce waste and facilitate healthier, more sustainable consumption.

Recent Event

Medolife Rx (Quanta, Inc. OTC: QNTA) Investor Conference Call

Latest Financial Results

Q1 2022

Quarter Ended Mar 31, 2022

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2021

Investor Contact Information


Quanta, Inc.
632 S Glenwood Pl.
Burbank, CA 91405

Investor Relations

T: 818-659-8052

Transfer Agent

Action Stock Transfer Corporation
2469 E. Fort Union Blvd
Suite 214
Salt Lake City, UT 84121
T: 801-274-1088

Market Data copyright © 2022 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.